Literature DB >> 2222379

Use of a dietary supplement in koalas during systemic antibiotic treatment of chlamydial infection.

R Osawa1, F N Carrick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2222379     DOI： 10.1111/j.1751-0813.1990.tb07805.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN： 0005-0423            Impact factor:   1.281


× No keyword cloud information.
  4 in total

1.  Characterization of shifts of koala (Phascolarctos cinereus) intestinal microbial communities associated with antibiotic treatment.

Authors:  Katherine E Dahlhausen; Ladan Doroud; Alana J Firl; Adam Polkinghorne; Jonathan A Eisen
Journal:  PeerJ       Date:  2018-03-12       Impact factor: 2.984

2.  Optimising the short and long-term clinical outcomes for koalas (Phascolarctos cinereus) during treatment for chlamydial infection and disease.

Authors:  Amy Robbins; Joanne Loader; Peter Timms; Jonathan Hanger
Journal:  PLoS One       Date:  2018-12-27       Impact factor: 3.240

3.  Antibiotic treatment of Chlamydia-induced cystitis in the koala is linked to expression of key inflammatory genes in reactive oxygen pathways.

Authors:  Samuel Phillips; Bonnie L Quigley; Ammar Aziz; Wendy Bergen; Rosemary Booth; Michael Pyne; Peter Timms
Journal:  PLoS One       Date:  2019-08-15       Impact factor: 3.240

4.  Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia pecorum.

Authors:  Emma Peel; Yuanyuan Cheng; Julianne T Djordjevic; Denis O'Meally; Mark Thomas; Michael Kuhn; Tania C Sorrell; Wilhelmina M Huston; Katherine Belov
Journal:  PLoS One       Date:  2021-04-14       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.